Markus Schott is the co-head of the firm’s life science group and one of Switzerland’s leading lawyers in the field of life sciences. Markus Schott has broad experience in all kinds of regulatory law matters including governmental licences, authorisations and supervision, pricing regimes, sanctions and industry codes. He advises and represents pharmaceutical and medtech companies, laboratories, hospitals and other actors in the healthcare, cosmetics, food and beverage sectors, research institutions and governmental agencies.
He also drafts expert opinions and also has an exceptional track record representing clients in court proceedings. As such, he regularly acts as party counsel before the Federal Administrative Tribunal and the Federal Supreme Court.
Markus Schott teaches public economic law as a law professor at the University of Zurich. He regularly publishes and speaks on conferences in his fields of expertise, and he has written important parts of the commentary on the Federal Act on Medicines and Medical Devices (2nd edition 2022) as well as an edited textbook of the Swiss law on therapeutic products (2022). He is listed in the categories of life sciences and healthcare in Who’s Who Legal.